Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Techniclone (TCLN) -- Ignore unavailable to you. Want to Upgrade?

To: Maurice Winn who wrote (2788)	12/10/1998 9:00:00 AM
From: shero	Read Replies (1) \| Respond to of 3702

Golfdad97--Here we are in the last month of 1998. We have a new management team going into the new year. I share the frustration from listening, for 15 years, to reasons that TCLN can't say this or that. However I won't engage in management bashing. Here's why--everyone believes that a licensing deal is imminent. I do too!! If that is the case talking publically about the interim results probably wouldn't help get the deal done. Probably hurt us. The future partner is, or will have spent alot of time and money on due diligence, reviewing confidential data, and they probably, at this time, want to keep it that way. Confidential. TCLN has over 10 centers involved and I beleive that they have treated between 20 and 30 patients. There is alot of data. With all of this data if a deal gets done we can assume very sophisticated people have decided that this is an approvable drug. If a deal doesn't get done...we're screwed. After a licensing deal is complete, and it seems from the consensus we won't have to wait long, our future partner may decide to publish everything, or nothing. But the simple fact that at this stage, with all the years of clinical experience someone who knows alot more than me plunked down cold, hard cash speaks volumes. That's good enough for me. I've waited as long, or longer, than most shareholders. I'm willing to give this new mgmt team some more time. If we don't see a deal in Jan. or sooner, or some kind of report, I'll start getting nervous.

To: Maurice Winn who wrote (2788)	12/13/1998 9:59:00 AM
From: EPS	Read Replies (2) \| Respond to of 3702

I think that TCLN will prove its business viability if (and only if) it can combine BOTH research and licensing agreements. (OT) "PS: Victor, I've already covered your points so don't want to rehash it. If you choose not to see my logic, then that's up to you. Shareholders aren't feeling their pain magnified 7 times as it is a matter of percentages, orders of magnitude or whatever you like. Adding zeroes doesn't affect it. Measuring the length of something in inches, centimetres or Angstroms doesn't change it's length." Hmm: quote.yahoo.com one possible explanation (but not the only one, in previous exchange we have agreed that reverse splits are just an attempt to attack the symptoms rather than the causes. Ergo: without real fundamental changes a reverse split will not by itself alter the course of history. Moreover a reverse split will usually expose shareholders to extreme pain as it tends to magnify the weaknesses of the issue: Thursday November 5, 9:16 am Eastern Time Cytel sets 1-for-7 reverse stock split SAN DIEGO, Nov 5 (Reuters) - Cytel Corp. said Thursday it had approved a one-for-seven reverse stock split effective November 13. The trading symbol for Cytel will be CYTLD (CYTLD - news) for the first 20 days after the reverse split takes effect. After the reverse split, Cytel will have about 5 million shares of common stock outstanding. ======================== so if you owned 7,000 shares @ 1/2 = $ 3,500 after the reverse split you own 1,000 shares @ 2 3/8 = $ 2,400 for a loss of $1,100, i.e roughly 1/3 of your money is gone..but probably you "ain't seen nothing yet" ..to be continued?? VD